Major Pharmaceuticals Recalls Levothyroxine Sodium Tablets Due to Subpotency

Major Pharmaceuticals has issued a recall of levothyroxine sodium tablets in various counts and strengths across the U.S. The recall was initiated because the medication was found to be a 'subpotent drug,' though further details were not immediately provided by the FDA. Levothyroxine sodium is a commonly prescribed thyroid hormone replacement therapy.